2,600
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Similar risk of complete revision for infection with single-dose versus multiple-dose antibiotic prophylaxis in primary arthroplasty of the hip and knee: results of an observational cohort study in the Dutch Arthroplasty Register in 242,179 patients

, , , , , & show all

  • AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 2008; 90(7): 915–19.
  • American Academy of Orthopaedic Surgeons/American Association of Orthopaedic Surgeons. Information statement: recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty; 2014. https://www.aaos.org/globalassets/about/bylaws-library/information-statements/1027-recommendations-for-the-use-of-intravenous-antibiotic-prophylaxis-in-primary-total-joint-arthroplasy.pdf
  • Berrios-Torres S I, Umscheid C A, Bratzler D W, Leas B, Stone E C, Kelz R R, Reinke C E, Morgan S, Solomkin J S, Mazuski J E, Dellinger E P, Itani K M F, Berbari E F, Segreti J, Parvizi J, Blanchard J, Allen G, Kluytmans J A J W, Donlan R, Schecter W P. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection 2017. JAMA Surg 2017; 152(8): 784–91.
  • Blom A W, Taylor A H, Pattison G, Whitehouse S, Bannister G C. Infection after total hip arthroplasty: the Avon experience. J Bone Joint Surg Br 2003; 85(7): 956–9.
  • Bor J. Capitalizing on natural experiments to improve our understanding of population health. Am J Public Health 2016; 106(8): 1388–9.
  • Dale H, Fenstad A M, Hallan G, Havelin L I, Furnes O, Overgaard S, Pedersen A B, Karrholm J, Garellick G, Pulkkinen P, Eskelinen A, Makela K, Engesaeter L B. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop 2012; 83(5): 449–58.
  • Dutch Arthroplasty Register (LROI). Annual report 2014: Arthroplasty in the picture; 2014.
  • Dutch Arthroplasty Register (LROI). LROI annual report 2017: 10 years of registration, a wealth of information; 2017.
  • Engesaeter L B, Lie S A, Espehaug B, Furnes O, Vollset S E, Havelin L I. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003; 74(6): 644–51.
  • Gundtoft P H, Overgaard S, Schonheyder H C, Moller J K, Kjaersgaard-Andersen P, Pedersen A B. The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop 2015; 86(3): 326–34.
  • Hansen E, Belden K, Silibovsky R, Vogt M, Arnold W, Bicanic G, Bini S, Catani F, Chen J, Ghazavi M, Godefroy K M, Holham P, Hosseinzadeh H, Kim K I, Kirketerp-Moller K, Lidgren L, Lin J H, Lonner J H, Moore C C, Papagelopoulos P, Poultsides L, Randall R L, Roslund B, Saleh K, Salmon J V, Schwarz E, Stuyck J, Dahl A W, Yamada K. Perioperative antibiotics. J Orthop Res 2014; 32(Suppl. 1): S31–S59.
  • Heydemann J S, Nelson C L. Short-term preventive antibiotics. Clin Orthop Relat Res 1986; (205): 184–7.
  • Hickson C J, Metcalfe D, Elgohari S, Oswald T, Masters J P, Rymaszewska M, Reed M R, Sprowson A P. Prophylactic antibiotics in elective hip and knee arthroplasty: an analysis of organisms reported to cause infections and national survey of clinical practice. Bone Joint Res 2015; 4(11): 181–9.
  • Illingworth K D, Mihalko W M, Parvizi J, Sculco T, McArthur B, el B Y, Saleh K J. How to minimize infection and thereby maximize patient outcomes in total joint arthroplasty: a multicenter approach: AAOS exhibit selection. J Bone Joint Surg Am 2013; 95(8): e50.
  • Kanellakopoulou K, Papadopoulos A, Varvaroussis D, Varvaroussis A, Giamarellos-Bourboulis E J, Pagonas A, Stergiou A, Papadelis P, Nikolaidis V, Giamarellou H. Efficacy of teicoplanin for the prevention of surgical site infections after total hip or knee arthroplasty: a prospective, open-label study. Int J Antimicrob Agents 2009; 33(5): 437–40.
  • Kunutsor S K, Beswick A D, Whitehouse M R, Wylde V, Blom A W. Debridement, antibiotics and implant retention for periprosthetic joint infections: a systematic review and meta-analysis of treatment outcomes. J Infect 2018a; 77(6): 479–88.
  • Kunutsor S K, Whitehouse M R, Blom A W, Board T, Kay P, Wroblewski B M, Zeller V, Chen S Y, Hsieh P H, Masri B A, Herman A, Jenny J Y, Schwarzkopf R, Whittaker J P, Burston B, Huang R, Restrepo C, Parvizi J, Rudelli S, Honda E, Uip D E, Bori G, Munoz-Mahamud E, Darley E, Ribera A, Canas E, Cabo J, Cordero-Ampuero J, Redo M L S, Strange S, Lenguerrand E, Gooberman-Hill R, Webb J, MacGowan A, Dieppe P, Wilson M, Beswick A D. One- and two-stage surgical revision of peri-prosthetic joint infection of the hip: a pooled individual participant data analysis of 44 cohort studies. Eur J Epidemiol 2018b; 33: 933–46.
  • Kurtz S M, Ong K L, Lau E, Bozic K J. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am 2014; 96(8): 624–30.
  • Lenguerrand E, Whitehouse M R, Beswick A D, Jones S A, Porter M L, Blom A W. Revision for prosthetic joint infection following hip arthroplasty: evidence from the National Joint Registry. Bone Joint Res 2017a; 6(6): 391–8.
  • Lenguerrand E, Whitehouse M R, Beswick A D, Toms A D, Porter M L, Blom A W. Description of the rates, trends and surgical burden associated with revision for prosthetic joint infection following primary and revision knee replacements in England and Wales: an analysis of the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. BMJ Open 2017b; 7(7): e014056.
  • Lenguerrand E, Whitehouse M R, Beswick A D, Kunutsor S K, Burston B, Porter M, Blom A W. Risk factors associated with revision for prosthetic joint infection after hip replacement: a prospective observational cohort study. Lancet Infect Dis 2018; 18(9): 1004–14.
  • Maradit K H, Larson D R, Crowson C S, Kremers W K, Washington R E, Steiner C A, Jiranek W A, Berry D J. Prevalence of total hip and knee replacement in the United States. J Bone Joint Surg Am 2015; 97(17): 1386–97.
  • Moore A J, Blom A W, Whitehouse M R, Gooberman-Hill R. Deep prosthetic joint infection: a qualitative study of the impact on patients and their experiences of revision surgery. BMJ Open 2015; 5(12): e009495.
  • National Joint Registry for England and Wales. 15th Annual Report 2018; 2018. https://www.hqip.org.uk/resource/national-joint-registry-15th-annual-report-2018/
  • Nederlandse Orthopaedische Vereniging. Richtlijn perioperatieve zorg van totale heupprothese/preventie van wondinfectie bij heupprothese; 2018. https://www.hqip.org.uk/resource/national-joint-registry-15th-annual-report-2018/
  • Parvizi J, Gehrke T. Proceedings of the Second International Consensus on Musculoskeletal Infection; 2018. https://www.arthroplastyjournal.org/issue/S0883-5403(18)X0012-6
  • Parvizi J, Zmistowski B, Della V C, Bauer T W, Malizos K N, Alavi A, Bedair H, Booth R E, Choong P, Deirmengian C, Ehrlich G D, Gambir A, Huang R, Kissin Y, Kobayashi H, Kobayashi N, Krenn V, Lorenzo D, Marston S B, Meermans G, Perez J, Ploegmakers J J, Rosenberg A, Simpendorfer C, Thomas P, Tohtz S, Villafuerte J A, Wahl P, Wagenaar F C, Witzo E. Diagnosis of periprosthetic joint infection. J Arthroplasty 2013. PMID: 24342275
  • Poultsides L A, Liaropoulos L L, Malizos K N. The socioeconomic impact of musculoskeletal infections. J Bone Joint Surg Am 2010; 92(11): e13.
  • Ritter M A, Campbell E, Keating E M, Faris P M. Comparison of intraoperative versus 24 hour antibiotic prophylaxis in total joint replacement: a controlled prospective study. Orthop Rev 1989; 18(6): 694–6.
  • Royston P, Lambert P C. Time-dependent effects. In: Flexible parametric survival analysis using Stata: beyond the Cox model. College Station,TX: Stata Press 2011. p. 184–9.
  • Stefansdottir A, Robertsson O, Dahl A, Kiernan S, Gustafson P, Lidgren L. Inadequate timing of prophylactic antibiotics in orthopedic surgery: we can do better. Acta Orthop 2009; 80(6): 633–8.
  • Steinberg J P, Braun B I, Hellinger W C, Kusek L, Bozikis M R, Bush A J, Dellinger E P, Burke J P, Simmons B, Kritchevsky S B. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg 2009; 250(1): 10–16.
  • Swierstra B A, Bijlsma J W, de Beer J J, Kuijpers T. [Guideline “Diagnostics and treatment of osteoarthrosis of the hip and knee”]. Ned Tijdschr Geneeskd 2009; 153: B39.
  • Tan T L, Shohat N, Rondon A J, Foltz C, Goswami K, Ryan S P, Seyler T M, Parvizi J. Perioperative antibiotic prophylaxis in total joint arthroplasty: a single dose is as effective as multiple doses. J Bone Joint Surg Am 2019; 101(5): 429–37.
  • Thornley P, Evaniew N, Riediger M, Winemaker M, Bhandari M, Ghert M. Postoperative antibiotic prophylaxis in total hip and knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. CMAJ Open 2015; 3(3): E338–E343.
  • van Steenbergen L N, Denissen G A, Spooren A, van Rooden S M, van Oosterhout F J, Morrenhof J W, Nelissen R G. More than 95% completeness of reported procedures in the population-based Dutch Arthroplasty Register. Acta Orthop 2015; 86(4): 498–505.
  • Veltman E S, Moojen D J F, Nelissen R G, Poolman R W. Antibiotic prophylaxis and DAIR treatment in primary total hip and knee arthroplasty, a national survey in the Netherlands. J Bone Jt Infect 2018; 3(1): 5–9.
  • Wouthuyzen-Bakker M, Sebillotte M, Huotari K, Escudero S R, Benavent E, Parvizi J, Fernandez-Sampedro M, Barbero-Allende J M, Garcia-Canete J, Trebse R, Del T M, Diaz-Brito V, Sanchez M, Scarborough M, Soriano A. Lower success rate of debridement and implant retention in late acute versus early acute periprosthetic joint infection caused by Staphylococcus spp: results from a matched cohort study. Clin Orthop Relat Res 2020; 478(6): 1348–55.
  • Wyles C C, Hevesi M, Osmon D R, Park M A, Habermann E B, Lewallen D G, Berry D J, Sierra R J. 2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis. Bone Joint J 2019; 101-B(6_Supple_B): 9–15.
  • Wymenga A, van H J, Theeuwes A, Muytjens H, Slooff T. Cefuroxime for prevention of postoperative coxitis: one versus three doses tested in a randomized multicenter study of 2,651 arthroplasties. Acta Orthop Scand 1992; 63(1): 19–24.
  • Yates A J Jr. Postoperative prophylactic antibiotics in total joint arthroplasty. Arthroplast Today 2018; 4(1): 130–1.
  • Zmistowski B, Karam J A, Durinka J B, Casper D S, Parvizi J. Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am 2013; 95(24): 2177–84.